Current role
Biotechnology · Healthcare
Chairman, Board Member
2021-01-01–present
Neil Desai
Chairman
Whitehawk Therapeutics, Inc. (WHWK)Board Member
Whitehawk Therapeutics, Inc. (WHWK)Equibles does not estimate personal net worth.
Get an email with a short summary when Whitehawk Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get WHWK alertsAbout Neil Desai
Neil Desai is recorded as Chairman and Board Member at Whitehawk Therapeutics, Inc. (WHWK) since January 1, 2021. The newest filing on record that lists Neil Desai as Board Member at Whitehawk Therapeutics, Inc. (WHWK) is dated April 28, 2026. Whitehawk Therapeutics, Inc. reported in an 8-K filed November 9, 2022 that Neil Desai was appointed Executive Chairman, effective January 1, 2023. The proxy statement of Whitehawk Therapeutics, Inc. reports total compensation of $1,659,751 for Neil Desai in fiscal 2024, including a base salary of $484,512. Disclosed compensation is on record for 4 fiscal years. Whitehawk Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Whitehawk Therapeutics, Inc. includes Brendan Delaney (CEO, COO and Board Member), David J. Lennon (CEO and Board Member), David Lennon (CEO and Board Member) and 7 others.
“On November 8, 2022, the Company announced the appointment of Neil Desai, founder, director, President and Chief Executive Officer of the Company, to Executive Chairman of the Company and Brendan Delaney, Chief Operating Officer, to President and Chief Executive Officer of the Company, effective as of January 1, 2023 (the "Effective Date").”
Affiliation history
-
Current
2021-01-01–present
-
Current
2021-01-01–present
Last confirmed April 28, 2026
-
2021-01-01–2024-10-01
-
Whitehawk Therapeutics, Inc. (WHWK)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
-
Start not stated–2022-04-26
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Whitehawk Therapeutics, Inc.
- Brendan Delaney CEO, COO, Board Member
- David J. Lennon CEO, Board Member
- David Lennon CEO, Board Member
- Neil Desai, Ph.D. CEO, Board Member
- Stephen Hoffman CEO
- Caley Castelein, M.D. Chairman
- Lance Thibault CFO
- Scott Giacobello CFO, Chief Accounting Officer
- Anupam Dalal Board Member
- Anupam Dalal, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Whitehawk Therapeutics, Inc. (WHWK) | Former Executive Chairman | $484,512 | $1,659,751 |
| 2023 | Whitehawk Therapeutics, Inc. (WHWK) | Former Executive Chairman | $638,040 | $2,162,314 |
| 2022 | Whitehawk Therapeutics, Inc. (WHWK) | Executive Chairman | $618,120 | $3,052,812 |
| 2021 | Whitehawk Therapeutics, Inc. (WHWK) | Executive Chairman | $465,791 | $3,740,262 |